Investor · Chicago, IL

Peter Courossi

Open Peter in the network graph →

Filings

11

SEC Form D

Connections

64

co-filers

Capital

$46.1M

across filings

Active

Mar 2012

to Mar 2024

Most-connected co-filers (64)

John Knopf · CAMBRIDGE, MA8 shared David Cooper · Pittsburgh, PA5 shared Satyen Mehta · New York, NY5 shared Graham H. Cook · Grand Cayman, Cayman Islands5 shared Alejandro Baez-Sacasa · New York, NY5 shared R. P. Herget, Iii · Alexandria, VA5 shared Arun Gupta · Norcross, GA5 shared Richard F. Pops · CAMBRIDGE, MA3 shared Jasbir S. Seehra · Lexington, MA3 shared Terry Mcguire · CAMBRIDGE, MA3 shared Jean C. George · Cambridge, MA3 shared Pat Gage · Urbandale, IA3 shared Jeff Closs · Santa Barbara, CA3 shared Ed Kania · CAMBRIDGE, MA3 shared Anthony J. Evnin · Seattle, WA3 shared Carl L. Gordon · New York, NY3 shared Thomas Proulx · San Francisco, CA3 shared Matthew Sherman · Lexington, MA3 shared Guido Neels · Watertown, MA3 shared Jed H. Katz · San Francisco, CA3 shared Tom A. Maniatis · Cambridge, MA3 shared Michael Gertner · BELLEVUE, WA3 shared Charles A. Taylor · Redwood City, CA3 shared Wylie W. Vale · CAMBRIDGE, MA3 shared

Recent filings (11)

Nocion Therapeutics, Inc.Mar 2024 · 28 co-filers$70.0M Nocion Therapeutics, Inc.Mar 2024 · 28 co-filers$70.0M TRACT Therapeutics, Inc.Apr 2019 · 7 co-filers$15.0M TRACT Therapeutics, Inc.Apr 2019 · 7 co-filers$15.0M Neon Liberty Emerging Markets Fund Ltd.Oct 2012 · 7 co-filers Neon Liberty Emerging Markets Fund Ltd.Sep 2012 · 7 co-filers Kala Pharmaceuticals, Inc.Mar 2012 · 12 co-filers$7.2M Kala Pharmaceuticals, Inc.Mar 2012 · 12 co-filers$7.2M Neon Liberty Emerging Markets Fund Ltd.Sep 2011 · 7 co-filers Neon Liberty Emerging Markets Fund Ltd.Sep 2010 · 7 co-filers ACCELERON PHARMA INCJul 2010 · 25 co-filers$11.5M ACCELERON PHARMA INCJun 2010 · 25 co-filers$11.5M ACCELERON PHARMA INCDec 2009 · 25 co-filers$11.0M Neon Liberty Emerging Markets Fund Ltd.Sep 2009 · 7 co-filers

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Peter in the interactive graph →